New Delhi News

Psoriatic Arthritis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Sun Pharma, Birstol-Myers Squibb, Nimbus Therapeutics

 Breaking News
  • No posts were found

Psoriatic Arthritis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Sun Pharma, Birstol-Myers Squibb, Nimbus Therapeutics

November 14
23:41 2022
Psoriatic Arthritis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies - Sun Pharma, Birstol-Myers Squibb, Nimbus Therapeutics
The Psoriatic Arthritis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Psoriatic Arthritis pipeline products will significantly revolutionize the Psoriatic Arthritis market dynamics.

DelveInsight’s “Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Psoriatic Arthritis, historical and forecasted epidemiology as well as the Psoriatic Arthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Psoriatic Arthritis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

 

To Know in detail about the Psoriatic Arthritis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Psoriatic Arthritis Market Insights

 

Psoriatic Arthritis Overview

Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory rheumatic disease characterized by pain, stiffness, swollen joints, joint erosion, and bone formation. Clinical manifestations vary greatly between patients. It can present with oligoarticular joint involvement that is typically asymmetric or as a polyarticular disease affecting five or more joints, usually with asymmetric distribution similar to that of rheumatoid arthritis.

 

Some of the key facts of the Psoriatic Arthritis Market Report: 

  • The Psoriatic Arthritis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • According to the National Psoriatic foundation, about 1 in 3 people or 30% with psoriasis develop psoriatic arthritis (PsA) – as many as 2.4 million Americans – and PsA can develop at any age.
  • Key Psoriatic Arthritis Companies: Sun Pharma, Birstol-Myers Squibb, Nimbus Therapeutics, UCB Biopharma, Pfizer, and others
  • Key Psoriatic Arthritis Therapies: Ilumya, Deucravacitinib, NDI-034858, Bimekizumab, Brepocitinib, and others
  • The Psoriatic Arthritis epidemiology based on severity analyzed that there is no gender based difference but prevalence of severe cases is the highest followed by moderate and mild

 

Get a Free sample for the Psoriatic Arthritis Market Report 

 

Key benefits of the Psoriatic Arthritis Market report:

  1. Psoriatic Arthritis market report covers a descriptive overview and comprehensive insight of the Psoriatic Arthritis Epidemiology and Psoriatic Arthritis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Psoriatic Arthritis market report provides insights on the current and emerging therapies.
  3. Psoriatic Arthritis market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Psoriatic Arthritis market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Psoriatic Arthritis market.

 

Download the report to understand which factors are driving Psoriatic Arthritis epidemiology trends @ Psoriatic Arthritis Epidemiological Insights 

 

Psoriatic Arthritis Market  

The dynamics of the Psoriatic Arthritis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such and others during the forecasted period 2019-2032.  

 

Psoriatic Arthritis Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Psoriatic Arthritis Epidemiology Segmentation:

The Psoriatic Arthritis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Psoriatic Arthritis
  • Prevalent Cases of Psoriatic Arthritis by severity
  • Gender-specific Prevalence of Psoriatic Arthritis
  • Diagnosed Cases of Episodic and Chronic Psoriatic Arthritis

 

Psoriatic Arthritis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Psoriatic Arthritis market or expected to get launched during the study period. The analysis covers Psoriatic Arthritis market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Psoriatic Arthritis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Discover more about therapies set to grab major Psoriatic Arthritis market share @ Psoriatic Arthritis market forecast 

 

Psoriatic Arthritis Therapies and Key Companies

  • Ilumya: Sun Pharma
  • Deucravacitinib: Birstol-Myers Squibb
  • NDI-034858: Nimbus Therapeutics
  • Bimekizumab: UCB Biopharma
  • Brepocitinib: Pfizer

 

Psoriatic Arthritis Market Drivers

  • Widespread prevalence of disease
  • The Robust clinical pipeline containing emerging drugs with novel RoA and MoA holds promising future therapies

 

Scope of the Psoriatic Arthritis Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Psoriatic Arthritis Companies: Sun Pharma, Birstol-Myers Squibb, Nimbus Therapeutics, UCB Biopharma, Pfizer, and others
  • Key Psoriatic Arthritis Therapies: Ilumya, Deucravacitinib, NDI-034858, Bimekizumab, Brepocitinib, and others
  • Psoriatic Arthritis Therapeutic Assessment: Psoriatic Arthritis current marketed and Psoriatic Arthritis emerging therapies
  • Psoriatic Arthritis Market Dynamics: Psoriatic Arthritis market drivers and Psoriatic Arthritis market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Psoriatic Arthritis Unmet Needs, KOL’s views, Analyst’s views, Psoriatic Arthritis Market Access and Reimbursement 

 

Psoriatic Arthritis Market Barriers

  • Challenges in Psoriatic Arthritis diagnosis
  • Development of novel therapies
  • Limitations in gene therapy
  • Poor disease understanding
  • Clinical biomarkers

 

Table of Contents 

1. Psoriatic Arthritis Market Report Introduction

2. Executive Summary for Psoriatic Arthritis

3. SWOT analysis of Psoriatic Arthritis

4. Psoriatic Arthritis Patient Share (%) Overview at a Glance

5. Psoriatic Arthritis Market Overview at a Glance

6. Psoriatic Arthritis Disease Background and Overview

7. Psoriatic Arthritis Epidemiology and Patient Population

8. Country-Specific Patient Population of Psoriatic Arthritis 

9. Psoriatic Arthritis Current Treatment and Medical Practices

10. Psoriatic Arthritis Unmet Needs

11. Psoriatic Arthritis Emerging Therapies

12. Psoriatic Arthritis Market Outlook

13. Country-Wise Psoriatic Arthritis Market Analysis (2019–2032)

14. Psoriatic Arthritis Market Access and Reimbursement of Therapies

15. Psoriatic Arthritis Market Drivers

16. Psoriatic Arthritis Market Barriers

17.  Psoriatic Arthritis Appendix

18. Psoriatic Arthritis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Psoriatic Arthritis treatment, visit @ Psoriatic Arthritis Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com

Related Articles